THOMASINA ANDERSON-SHARPE, MD

New patient office or other outpatient visit, 60-74 minutes

New patient office or other outpatient visit, 45-59 minutes

Established patient office or other outpatient visit, 40-54 minutes

Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected

Established patient office or other outpatient visit, 30-39 minutes

X-ray series of abdomen with single x-ray of chest

Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus

Established patient office or other outpatient visit, 20-29 minutes

Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)

X-ray of chest, 2 views

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report

Inhalation treatment for airway obstruction or sputum production

Administration of vaccine

Injection of drug or substance under skin or into muscle

Detection test by immunoassay with direct visual observation for influenza virus

Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

Blood test, basic group of blood chemicals (calcium, ionized)

Injection, ceftriaxone sodium, per 250 mg

Urinalysis, manual test

Insertion of needle into vein for collection of blood sample

Injection, ketorolac tromethamine, per 15 mg

Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme

Injection, dexamethasone sodium phosphate, 1 mg